RxDoctor Payments Data

Christopher Busken, MD

Vascular Surgery · Live Oak, TXNPI 1548313455

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Endologix LLC accounts for 71.1% of it on its own, with 32 other manufacturers making up the rest. 2025 is the largest year on record at $32,504, more than ten times the $2,613 reported in 2019.

$45,579in general payments, 2019–2025

Across 391 payments — averaging $116.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Endologix LLC$32K
  • Angiodynamics, Inc.$2K
  • Inari Medical, Inc.$2K
  • Medtronic$1K
  • Cardiovascular Systems Inc.$1K
  • W. L. Gore & Associates, Inc.$1K
  • plus $6K from 27 others

What the payments were for

  • Consulting fees$24,60054%
  • Travel & lodging$4,51510%
  • Food & beverage$16,46436%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,579 in reported general payments places this provider in the 85th percentile of 347 vascular surgery providers in Texas.

See all vascular surgery providers in Texas

Medicare billing

Part B allowed, 2024
$275,347
Medicare patients
342
Services billed
1,915

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban36$27,325
ClopidogrelClopidogrel Bisulfate80$901
Atorvastatin Calcium63$758
Triamcinolone Acetonide55$398
Amlodipine Besylate16$45

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Live Oak

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →